Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Market Reports
NEW
 Top 50 Non-Healthcare Market Reports
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Glycomic Therapeutics Global Market Report 2025
Download Free Sample Buy Now
Global Glycomic Therapeutics Market Report 2025

Report Price : $4490.00

Pages :

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF
Purchase This Report

Glycomic Therapeutics Global Market Report 2025

By Class (Isolated, Synthetic), By Structures (Glycoproteins, Targeting Sialic Acid, Proteoglycans, Targeting Glycosaminoglycans, Glycosylphosphatidylinositol (GPI)-Anchored Proteins And Heparin Based Glycans, Targeting Glycosphingolipids, Other Structures), By Mode Of Action (Inhibits Neuraminidase, Inhibits Heparanase And Selectins And Blocks Interactions Between Growth Factors And Heparan Sulfate, Erythropoietin And Enzyme Replacement Therapy (ERT), Tissue Plasminogen Activator, Inhibits Glucosylceramide Synthase, Interleukin 1, 2 And 3, Beta And Gamma Interferons, Other Mode Of Action), By Indications (Thrombosis And Chemoprophylaxis, Anemia, Anti-Adhesive And Anti-Inflammatory, Cataracts, Gaucher’s Disease, Mps-1 And IV, Other Indications) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Glycomic Therapeutics Market Overview

• Glycomic Therapeutics market size has reached to $164.71 billion in 2024

• Expected to grow to $359.62 billion in 2029 at a compound annual growth rate (CAGR) of 17.4%

• Growth Driver: Rising Diabetes Prevalence Fuels Growth In The Glycomic Therapeutics Market

• Market Trend: Innovations In The Glycomic Therapeutics Market

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Glycomic Therapeutics Market?

Glycomic therapeutics refers to the development of glycomics-based approaches in the field of therapeutics. Glycome is the complete set of glycans in a cell or organism, which is important for unraveling the complexity of biological systems and their implications for health and disease. Glycan plays important roles in various biological processes, including cell signaling, immune response, and disease development.

The main glycomic therapeutics class types are isolated, and synthetic. Isolated glycomic therapy refers to the study or analysis of glycans in isolation, focusing specifically on the structural and functional characterization of individual glycan molecules and the therapeutic approach that involves the use of synthetic glycans or glycan-based molecules for the diagnosis and treatment of diseases or medical conditions. The various structures are glycoproteins, targeting sialic acid, proteoglycans, targeting glycosaminoglycans, glycosylphosphatidylinositol (GPI)-anchored proteins and heparin based glycans, targeting glycosphingolipids, others with various mode of actions such as inhibits neuraminidase, inhibits heparanase and selectins and blocks interactions between growth factors and heparan sulfate, erythropoietin and enzyme replacement therapy (ERT), tissue plasminogen activator, inhibits glucosylceramide synthase, interleukin 1, 2 and 3, beta and gamma interferons, others. The various indications are thrombosis and chemoprophylaxis, anemia, anti-adhesive and anti-inflammatory, cataracts; Gaucher’s Disease, mps-1 and IV, cancer, Alzheimer's disease, influenza type A and B, and others.

Glycomic Therapeutics Market Size and growth rate 2025 to 2029: Graph

What Is The Glycomic Therapeutics Market Size 2025 And Growth Rate?

The glycomic therapeutics market size has grown rapidly in recent years. It will grow from $164.71 billion in 2024 to $189.51 billion in 2025 at a compound annual growth rate (CAGR) of 15.1%. The growth in the historic period can be attributed to increased awareness of glycan significance, rise in chronic diseases, drug development for rare diseases, collaborations in glycomics research

What Is The Glycomic Therapeutics Market Growth Forecast?

The glycomic therapeutics market size is expected to see rapid growth in the next few years. It will grow to $359.62 billion in 2029 at a compound annual growth rate (CAGR) of 17.4%. The growth in the forecast period can be attributed to expanding knowledge of glycan biology, precision medicine approaches, rising interest in immunotherapy, increased funding for rare diseases research, emergence of glycan biomarkers. Major trends in the forecast period include expansion of glycomic applications in oncology, glycoengineering for enhanced therapeutic proteins, inclusion of glycomics in immuno-oncology, glycomics in rare and genetic disorders, regulatory considerations for glycomic drugs.

The forecast of 17.4% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. adoption of advanced glycobiology treatments by inflating prices of glycosylation-modifying drugs and diagnostic tools developed in Sweden and the Netherlands, resulting in delayed metabolic disease management and higher specialty pharmacy costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Glycomic Therapeutics Market Segmented?

1) By Class: Isolated, Synthetic

2) By Structures: Glycoproteins, Targeting Sialic Acid, Proteoglycans, Targeting Glycosaminoglycans, Glycosylphosphatidylinositol (GPI)-Anchored Proteins And Heparin Based Glycans, Targeting Glycosphingolipids, Other Structures

3) By Mode Of Action: Inhibits Neuraminidase, Inhibits Heparanase And Selectins And Blocks Interactions Between Growth Factors And Heparan Sulfate, Erythropoietin And Enzyme Replacement Therapy (ERT), Tissue Plasminogen Activator, Inhibits Glucosylceramide Synthase, Interleukin 1, 2 And 3, Beta And Gamma Interferons, Other Mode Of Action

4) By Indications: Thrombosis And Chemoprophylaxis, Anemia, Anti-Adhesive And Anti-Inflammatory, Cataracts, Gaucher’s Disease, Mps-1 And IV, Cancer, Alzheimer’s Disease, Influenza Type A And B, Other Indications

Subsegments:

1) By Isolated: Natural Glycans, Glycan Derivatives, Glycoproteins

2) By Synthetic: Chemically Synthesized Glycans, Recombinant Glycans, Glycopeptides

What Is Driving The Glycomic Therapeutics Market? Rising Diabetes Prevalence Fuels Growth In The Glycomic Therapeutics Market

The increase in the prevalence of diabetes is expected to drive the growth of the glycomic therapeutics market. Diabetes is a chronic medical condition that affects the body's ability to regulate blood sugar (glucose) levels. In diabetes, alterations in glycans have been observed, which can contribute to insulin resistance and other metabolic abnormalities. Specific glycan patterns serve as biomarkers for diagnosing diabetes, predicting its progression, and monitoring treatment responses. For instance, in March 2022, according to the IDF Diabetes Atlas, a Belgium-based global resource providing comprehensive data and insights on diabetes prevalence, the global prevalence of diabetes is projected to increase from 643 million in 2030 to 783 million by 2045, an addition of 140 million cases. Therefore, the increase in the prevalence of diabetes is driving the growth of the glycomic therapeutics industry.

What Is Driving The Glycomic Therapeutics Market? Rising Cancer Prevalence Fuels Growth In The Glycomic Therapeutics Market

The increasing prevalence of cancer is expected to propel the growth of the glycomic therapeutics market going forward. Cancer is a disease characterized by the uncontrolled growth and spread of abnormal cells in the body. Glycomic therapeutics are used in cancer treatment by targeting and modifying specific sugar molecules on cell surfaces, influencing critical cellular interactions, signaling pathways, and immune responses, with the aim of inhibiting tumor growth and enhancing the efficacy of cancer therapies. For instance, in 2023, according to a report published by the American Cancer Society, a US-based nationwide voluntary health organization dedicated to eliminating cancer, the estimated number of new cases of liver cancer in females diagnosed in the United States increased from 12,660 in 2022 to 13,230 in 2023. Therefore, the increasing prevalence of cancer is driving the growth of the glycomic therapeutics industry.

Who Are The Major Players In The Global Glycomic Therapeutics Market?

Major companies operating in the glycomic therapeutics market include F Hoffmann-La Roche Ltd., Bayer AG, Sanofi SA, Thermo Fisher Scientific Inc., GlaxoSmithKline plc, Merck KGaA, ICON plc, Agilent Technologies Inc., AMS Bio, Shimadzu Corporation, Waters Corporation, Bruker Corporation, BioMarin Pharmaceutical Inc., Bio Techne Corp., Promega Corporation, Halozyme Therapeutics Inc., Takara Bio Inc., Vector Laboratories, New England Biolabs Inc., Protalix Biotherapeutics Inc., Genovis AB, Ray Biotech Life Inc., IEC Group, Ludger Ltd, Z Biotech LLC, Alzheon Inc., GlycoMar Limited

What Are The Key Trends Of The Global Glycomic Therapeutics Market? Innovations In The Glycomic Therapeutics Market

Product innovation is a key trend gaining popularity in the glycomic therapeutics market. Major companies operating in the glycomic therapeutics sector are focused on developing new technological and innovative solutions to strengthen their position in the market. For instance, in April 2022, Glenmark Pharmaceuticals Limited, an India-based pharmaceutical company is discovering advanced therapies, launched a novel fixed-dose combination (FDC) of a DPP4 inhibitor (Dipeptidyl Peptidase 4 inhibitor), Teneligliptin, with Pioglitazone to improve glycemic control and to reduce insulin resistance in type 2 diabetes patients.

What Are The Key Trends Of The Global Glycomic Therapeutics Market? Screening Kits For Advanced Glycomic Therapeutics Exploration

Major companies operating in the glycomic therapeutics sector are focused on developing new technological and innovative solutions, such as screening kits to advance glycobiology research and exploration. A screening kit is essentially a pre-packaged set of tools and materials designed to perform a preliminary test for the presence or absence of a specific substance, condition, or property. For instance, in July 2022, Vector Laboratories, a US-based glycomic solutions provider company, launched Glysite Scout Glycan screening kits, which are fully integrated immunofluorescence kits for the detection of glycan expression in tissue sections. These kits will enable researchers to profile and characterize complex glycans in biological systems and detect the presence or absence of all major surface glycan motifs in a sample.

Need data on a specific region in this market?
Request Regional Data

Glycomic Therapeutics Market Merger And Acquisition: Halozyme Therapeutics Expands Portfolio With Acquisition Of Antares Pharma Inc

In May 2022, Halozyme Therapeutics, a US-based biotechnology company, acquired Antares Pharma Inc. for $960 million. This purchase enhanced the pipeline portfolio of novel treatments employing its superior drug delivery methods, which have increased safety and efficacy, convenience, tolerability, and patient comfort and adherence. Antares Pharma Inc is a US-based pharmaceutical firm.

Regional Outlook For The Global Glycomic Therapeutics Market

North America was the largest region in the glycomic therapeutics in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Glycomic Therapeutics Market?

The glycomic therapeutics market consists of sales of investigational glycomic therapeutics and therapeutic glycomic that target glycans or glycan-related pathways for the diagnosis and treatment of diseases. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Glycomic Therapeutics Industry?

The glycomic therapeutics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the glycomic therapeutics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Glycomic Therapeutics Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $189.51 billion
Revenue Forecast In 2034 $359.62 billion
Growth Rate CAGR of 17.4% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Class: Isolated, Synthetic
2) By Structures: Glycoproteins, Targeting Sialic Acid, Proteoglycans, Targeting Glycosaminoglycans, Glycosylphosphatidylinositol (GPI)-Anchored Proteins And Heparin Based Glycans, Targeting Glycosphingolipids, Other Structures
3) By Mode Of Action: Inhibits Neuraminidase, Inhibits Heparanase And Selectins And Blocks Interactions Between Growth Factors And Heparan Sulfate, Erythropoietin And Enzyme Replacement Therapy (ERT), Tissue Plasminogen Activator, Inhibits Glucosylceramide Synthase, Interleukin 1, 2 And 3, Beta And Gamma Interferons, Other Mode Of Action
4) By Indications: Thrombosis And Chemoprophylaxis, Anemia, Anti-Adhesive And Anti-Inflammatory, Cataracts, Gaucher’s Disease, Mps-1 And IV, Cancer, Alzheimer’s Disease, Influenza Type A And B, Other Indications Subsegments: 1) By Isolated: Natural Glycans, Glycan Derivatives, Glycoproteins
2) By Synthetic: Chemically Synthesized Glycans, Recombinant Glycans, Glycopeptides
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled F Hoffmann-La Roche Ltd., Bayer AG, Sanofi SA, Thermo Fisher Scientific Inc., GlaxoSmithKline plc, Merck KGaA, ICON plc, Agilent Technologies Inc., AMS Bio, Shimadzu Corporation, Waters Corporation, Bruker Corporation, BioMarin Pharmaceutical Inc., Bio Techne Corp., Promega Corporation, Halozyme Therapeutics Inc., Takara Bio Inc., Vector Laboratories, New England Biolabs Inc., Protalix Biotherapeutics Inc., Genovis AB, Ray Biotech Life Inc., IEC Group, Ludger Ltd, Z Biotech LLC, Alzheon Inc., GlycoMar Limited
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Glycomic Therapeutics Market Characteristics

3. Glycomic Therapeutics Market Trends And Strategies

4. Glycomic Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Glycomic Therapeutics Growth Analysis And Strategic Analysis Framework

5.1. Global Glycomic Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Glycomic Therapeutics Market Growth Rate Analysis

5.4. Global Glycomic Therapeutics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Glycomic Therapeutics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Glycomic Therapeutics Total Addressable Market (TAM)

6. Glycomic Therapeutics Market Segmentation

6.1. Global Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Isolated

Synthetic

6.2. Global Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Glycoproteins

Targeting Sialic Acid

Proteoglycans

Targeting Glycosaminoglycans

Glycosylphosphatidylinositol (GPI)-Anchored Proteins and Heparin-Based Glycans

Targeting Glycosphingolipids

Other Structures

6.3. Global Glycomic Therapeutics Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Inhibits Neuraminidase

Inhibits Heparanase and Selectins and Blocks Interactions Between Growth Factors and Heparan Sulfate

Erythropoietin and Enzyme Replacement Therapy (ERT)

Tissue Plasminogen Activator

Inhibits Glucosylceramide Synthase

Interleukin 1, 2, and 3

Beta and Gamma Interferons

Other Mode of Action

6.4. Global Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Thrombosis and Chemoprophylaxis

Anemia

Anti-Adhesive and Anti-Inflammatory

Cataracts

Gaucher’s Disease

MPS-1 and IV

Cancer

Alzheimer’s Disease

Influenza Type A and B

Other Indications

6.5. Global Glycomic Therapeutics Market, Sub-Segmentation Of Isolated, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Natural Glycans

Glycan Derivatives

Glycoproteins

6.6. Global Glycomic Therapeutics Market, Sub-Segmentation Of Synthetic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Chemically Synthesized Glycans

Recombinant Glycans

Glycopeptides

7. Glycomic Therapeutics Market Regional And Country Analysis

7.1. Global Glycomic Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Glycomic Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Glycomic Therapeutics Market

8.1. Asia-Pacific Glycomic Therapeutics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Glycomic Therapeutics Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Glycomic Therapeutics Market

9.1. China Glycomic Therapeutics Market Overview

9.2. China Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Glycomic Therapeutics Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Glycomic Therapeutics Market

10.1. India Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Glycomic Therapeutics Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Glycomic Therapeutics Market

11.1. Japan Glycomic Therapeutics Market Overview

11.2. Japan Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Glycomic Therapeutics Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Glycomic Therapeutics Market

12.1. Australia Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Glycomic Therapeutics Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Glycomic Therapeutics Market

13.1. Indonesia Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Glycomic Therapeutics Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Glycomic Therapeutics Market

14.1. South Korea Glycomic Therapeutics Market Overview

14.2. South Korea Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Glycomic Therapeutics Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Glycomic Therapeutics Market

15.1. Western Europe Glycomic Therapeutics Market Overview

15.2. Western Europe Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Glycomic Therapeutics Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Glycomic Therapeutics Market

16.1. UK Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Glycomic Therapeutics Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Glycomic Therapeutics Market

17.1. Germany Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Glycomic Therapeutics Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Glycomic Therapeutics Market

18.1. France Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Glycomic Therapeutics Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Glycomic Therapeutics Market

19.1. Italy Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Glycomic Therapeutics Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Glycomic Therapeutics Market

20.1. Spain Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Glycomic Therapeutics Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Glycomic Therapeutics Market

21.1. Eastern Europe Glycomic Therapeutics Market Overview

21.2. Eastern Europe Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Glycomic Therapeutics Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Glycomic Therapeutics Market

22.1. Russia Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Glycomic Therapeutics Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Glycomic Therapeutics Market

23.1. North America Glycomic Therapeutics Market Overview

23.2. North America Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Glycomic Therapeutics Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Glycomic Therapeutics Market

24.1. USA Glycomic Therapeutics Market Overview

24.2. USA Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Glycomic Therapeutics Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Glycomic Therapeutics Market

25.1. Canada Glycomic Therapeutics Market Overview

25.2. Canada Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Glycomic Therapeutics Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Glycomic Therapeutics Market

26.1. South America Glycomic Therapeutics Market Overview

26.2. South America Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Glycomic Therapeutics Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Glycomic Therapeutics Market

27.1. Brazil Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Glycomic Therapeutics Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Glycomic Therapeutics Market

28.1. Middle East Glycomic Therapeutics Market Overview

28.2. Middle East Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Glycomic Therapeutics Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Glycomic Therapeutics Market

29.1. Africa Glycomic Therapeutics Market Overview

29.2. Africa Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Glycomic Therapeutics Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Glycomic Therapeutics Market Competitive Landscape And Company Profiles

30.1. Glycomic Therapeutics Market Competitive Landscape

30.2. Glycomic Therapeutics Market Company Profiles

30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis

31. Glycomic Therapeutics Market Other Major And Innovative Companies

31.1. Merck KGaA

31.2. ICON plc

31.3. Agilent Technologies Inc.

31.4. AMS Bio

31.5. Shimadzu Corporation

31.6. Waters Corporation

31.7. Bruker Corporation

31.8. BioMarin Pharmaceutical Inc.

31.9. Bio-Techne Corp.

31.10. Promega Corporation

31.11. Halozyme Therapeutics Inc.

31.12. Takara Bio Inc.

31.13. Vector Laboratories

31.14. New England Biolabs Inc.

31.15. Protalix Biotherapeutics Inc.

32. Global Glycomic Therapeutics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Glycomic Therapeutics Market

34. Recent Developments In The Glycomic Therapeutics Market

35. Glycomic Therapeutics Market High Potential Countries, Segments and Strategies

35.1 Glycomic Therapeutics Market In 2029 - Countries Offering Most New Opportunities

35.2 Glycomic Therapeutics Market In 2029 - Segments Offering Most New Opportunities

35.3 Glycomic Therapeutics Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Glycomic Therapeutics Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Glycomic Therapeutics Market, Sub-Segmentation Of Isolated, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Glycomic Therapeutics Market, Sub-Segmentation Of Synthetic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Glycomic Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Glycomic Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Asia-Pacific, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Glycomic Therapeutics Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: China, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Glycomic Therapeutics Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: India, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Glycomic Therapeutics Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Japan, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Glycomic Therapeutics Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Australia, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Glycomic Therapeutics Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Indonesia, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Glycomic Therapeutics Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: South Korea, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Glycomic Therapeutics Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Western Europe, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Glycomic Therapeutics Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: UK, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Glycomic Therapeutics Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Germany, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Glycomic Therapeutics Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: France, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Glycomic Therapeutics Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Italy, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Glycomic Therapeutics Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Spain, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Glycomic Therapeutics Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Eastern Europe, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Glycomic Therapeutics Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Russia, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Glycomic Therapeutics Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: North America, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Glycomic Therapeutics Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: USA, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Glycomic Therapeutics Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: Canada, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Glycomic Therapeutics Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: South America, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Glycomic Therapeutics Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Brazil, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Glycomic Therapeutics Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Middle East, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Glycomic Therapeutics Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Africa, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Glycomic Therapeutics Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: F. Hoffmann-La Roche Ltd. Financial Performance
  • Table 78: Bayer AG Financial Performance
  • Table 79: Sanofi SA Financial Performance
  • Table 80: Thermo Fisher Scientific Inc. Financial Performance
  • Table 81: GlaxoSmithKline plc Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Glycomic Therapeutics Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Glycomic Therapeutics Market, Sub-Segmentation Of Isolated, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Glycomic Therapeutics Market, Sub-Segmentation Of Synthetic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Glycomic Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Glycomic Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Asia-Pacific, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Glycomic Therapeutics Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: China, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Glycomic Therapeutics Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: India, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Glycomic Therapeutics Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Japan, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Glycomic Therapeutics Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Australia, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Glycomic Therapeutics Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Indonesia, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Glycomic Therapeutics Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: South Korea, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Glycomic Therapeutics Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Western Europe, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Glycomic Therapeutics Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: UK, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Glycomic Therapeutics Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Germany, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Glycomic Therapeutics Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: France, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Glycomic Therapeutics Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Italy, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Glycomic Therapeutics Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Spain, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Glycomic Therapeutics Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Eastern Europe, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Glycomic Therapeutics Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Russia, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Glycomic Therapeutics Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: North America, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Glycomic Therapeutics Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: USA, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Glycomic Therapeutics Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: Canada, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Glycomic Therapeutics Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: South America, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Glycomic Therapeutics Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Brazil, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Glycomic Therapeutics Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Middle East, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Glycomic Therapeutics Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Africa, Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Glycomic Therapeutics Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: F. Hoffmann-La Roche Ltd. Financial Performance
  • Figure 78: Bayer AG Financial Performance
  • Figure 79: Sanofi SA Financial Performance
  • Figure 80: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 81: GlaxoSmithKline plc Financial Performance

From Insight to Impact: Strategic Growth Mapping in the HER2-Positive Breast Cancer Market

Read More About From Insight to Impact: Strategic Growth Mapping in the HER2-Positive Breast Cancer Market

Hospital And Nursing Home Probiotics Market Overview 2025: Competitive Shifts, Forecast Models, and Emerging Opportunities

Read More About Hospital And Nursing Home Probiotics Market Overview 2025: Competitive Shifts, Forecast Models, and Emerging Opportunities

Next-Gen Implantable Cardioverter Defibrillators (ICDs) : Market Forecast, Transformation, and Long-Term Trajectories

Read More About Next-Gen Implantable Cardioverter Defibrillators (ICDs) : Market Forecast, Transformation, and Long-Term Trajectories

Indwelling Catheters Growth Trajectory: Key Forecasts and Strategic Insights

Read More About Indwelling Catheters Growth Trajectory: Key Forecasts and Strategic Insights

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Read More About A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Read More About A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Read More About A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Read More About Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Glycomic Therapeutics Global Market Report 2025 – By Class (Isolated, Synthetic), By Structures (Glycoproteins, Targeting Sialic Acid, Proteoglycans, Targeting Glycosaminoglycans, Glycosylphosphatidylinositol (GPI)-Ancho...

View Report

Glycomics or Glycobiology Global Market Report 2025 – By Product( Enzymes, Kits, Reagents and Chemicals, Instruments, Carbohydrates ), By Application( Drug Discovery and Development, Disease Diagnostics, Other Applicatio...

View Report

Glycopeptide Antibiotics Global Market Report 2025 – By Drug (Vancomycin, Dalbavancin, Oritavancin, Other Drugs), By Route of Administration (Oral, Parenteral, Other Routes), By Indication (Skin And Structure Infection, ...

View Report

Glycol Global Market Report 2025 – By Type (Ethylene Glycol, Propylene Glycol, Other Types), By Application (Antifreeze and Coolants, Polyester Fiber Production, PET Bottles and Packaging, Solvents and Humectants, Dehydr...

View Report

Glycerol Derivatives Global Market Report 2025 – By Product (4- (Hydroxymethyl)-1 3-Dioxolan-2-One, Polyglycerol, Propane-1 2 3-Triyl Triacetate, 1 3 Propanediol, Propylene Glycol, Other Products), By Grade (Bio-Based, P...

View Report

Glyphosate Global Market Report 2025 – By Crop Type (Genetically Modified Crops, Conventional Crops), By Form (Liquid, Dry), By Application (Grains and Cereals, Pulses and Oilseeds, Fruits and Vegetables, Commercial Crop...

View Report

Caprylyl Glycol Global Market Report 2025 – By Type (Cosmetic Grade, Industrial Grade), By Application (Haircare Products, Skincare Products, Toiletries, Makeup And Color Cosmetics, Other Applications), By End-Use (Pharm...

View Report

Antiglaucoma Drugs Market - By Product Type (Alpha Agonist, Beta Blockers, Prostaglandin Analogs, Combined Medication), By Disease Condition Type (Open-Angle Glaucoma, Angle-Closure Glaucoma, Normal-Tension Glaucoma, Con...

View Report

Frequently Asked Questions

Glycomic therapeutics refers to the development of glycomics-based approaches in the field of therapeutics. Glycome is the complete set of glycans in a cell or organism, which is important for unraveling the complexity of biological systems and their implications for health and disease. Glycan plays important roles in various biological processes, including cell signaling, immune response, and disease development. For further insights on this market, request a sample here

The market major growth driver - Rising Diabetes Prevalence Fuels Growth In The Glycomic Therapeutics Market. For further insights on this market, request a sample here

The glycomic therapeutics market size has grown rapidly in recent years. It will grow from $164.71 billion in 2024 to $189.51 billion in 2025 at a compound annual growth rate (CAGR) of 15.1%. The growth in the historic period can be attributed to increased awareness of glycan significance, rise in chronic diseases, drug development for rare diseases, collaborations in glycomics research. The glycomic therapeutics market size is expected to see rapid growth in the next few years. It will grow to " $359.62 billion in 2029 at a compound annual growth rate (CAGR) of 17.4%. The growth in the forecast period can be attributed to expanding knowledge of glycan biology, precision medicine approaches, rising interest in immunotherapy, increased funding for rare diseases research, emergence of glycan biomarkers. Major trends in the forecast period include expansion of glycomic applications in oncology, glycoengineering for enhanced therapeutic proteins, inclusion of glycomics in immuno-oncology, glycomics in rare and genetic disorders, regulatory considerations for glycomic drugs. For further insights on this market, request a sample here

The glycomic therapeuticsmarket covered in this report is segmented –
1) By Class: Isolated; Synthetic
2) By Structures: Glycoproteins; Targeting Sialic Acid; Proteoglycans; Targeting Glycosaminoglycans; Glycosylphosphatidylinositol (GPI)-Anchored Proteins And Heparin Based Glycans; Targeting Glycosphingolipids; Other Structures
3) By Mode Of Action: Inhibits Neuraminidase; Inhibits Heparanase And Selectins And Blocks Interactions Between Growth Factors And Heparan Sulfate; Erythropoietin And Enzyme Replacement Therapy (ERT); Tissue Plasminogen Activator; Inhibits Glucosylceramide Synthase; Interleukin 1, 2 And 3; Beta And Gamma Interferons; Other Mode Of Action
4) By Indications: Thrombosis And Chemoprophylaxis; Anemia; Anti-Adhesive And Anti-Inflammatory; Cataracts; Gaucher’s Disease; Mps-1 And IV; Cancer; Alzheimer’s Disease; Influenza Type A And B; Other Indications Subsegments:
1) By Isolated: Natural Glycans; Glycan Derivatives; Glycoproteins
2) By Synthetic: Chemically Synthesized Glycans; Recombinant Glycans; Glycopeptides For further insights on this market, request a sample here

North America was the largest region in the glycomic therapeutics in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the glycomic therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the glycomic therapeutics market include F Hoffmann-La Roche Ltd., Bayer AG, Sanofi SA, Thermo Fisher Scientific Inc., GlaxoSmithKline plc, Merck KGaA, ICON plc, Agilent Technologies Inc., AMS Bio, Shimadzu Corporation, Waters Corporation, Bruker Corporation, BioMarin Pharmaceutical Inc., Bio Techne Corp., Promega Corporation, Halozyme Therapeutics Inc., Takara Bio Inc., Vector Laboratories, New England Biolabs Inc., Protalix Biotherapeutics Inc., Genovis AB, Ray Biotech Life Inc., IEC Group, Ludger Ltd, Z Biotech LLC, Alzheon Inc., GlycoMar Limited . For further insights on this market, request a sample here.

Major trends in this market include Innovations In The Glycomic Therapeutics Market. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Glycomic Therapeutics Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top WhatsApp icon